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222a Monday, February 22, 2010Mitochondria are the energy producing organelles of eukaryotic cells. Owing
to their endosymbiotic evolutionary history, they contain their own genome
(mtDNA) that encodes for thirteen proteins essential for ATP production.
In mammalian cells, multiple mtDNAs are compacted into protein-DNA com-
plexes called "nucleoids". A major component of these nucleoids is the mito-
chondrial transcription factor A (TFAM), a member of the high mobility group
(HMG) family of proteins. This abundant protein binds DNA with little
sequence specificity, and is able to coat the entire mtDNAmolecule. It not only
serves a role in mtDNA packaging, but is also required for mitochondrial
transcription. At this point, dynamics of the TFAM-DNA interaction remain
unclear.
Experiments on single DNA molecules offer a very direct way to study TFAM
dynamics. Tethered Particle Motion (TPM) experiments show that the system
quickly equilibrates with the buffer, and that the end-to-end distance of the
DNA decreases upon TFAM binding. Manipulations of single DNA molecules
with two optical traps offer an explanation: TFAM decreases the DNA’s stiff-
ness (persistence length). A possible molecular mechanism for this decrease is
that TFAM introduces bends in the DNA.
Adding single-molecule fluorescence to the dual optical trap illuminates
TFAM’s binding behavior. Literally seeing TFAM on the DNA, we can
derive on- and off-rates, and determine that TFAM does not bind coopera-
tively. Interestingly and seemingly unrelated to its role in DNA organiza-
tion, we also observe that TFAM can rapidly bind single-stranded DNA
(ssDNA), but not when the ssDNA is under tension. The physiological
function of TFAM binding to ssDNA could be related to its regulation of
transcription.Symposium 9: Biophysics of the Failing Heart
1153-Symp
What is the Effect of A Familial Hypertrophic Cardiomyopathy Mutation
on Cardiac Myosin Function?
Susan Lowey.
University of Vermont, Burlington, VT, USA.
Familial hypertrophic cardiomyopathy (FHC) is a clinically and genetically
heterogeneous disease which is a major cause of heart failure. The landmark
discovery that a point mutation at residue 403 (R403Q) in the b-myosin heavy
chain (MHC) can cause a lethal form of FHC was made in 1990, but the effect
of this mutation on the functional properties of human cardiac myosin remains
poorly understood. One problem has been that the prevalent mouse model for
FHC expresses predominantly a-MHC. The b-MHC, however, is the predom-
inant isoform in the ventricles of all larger mammals. Even though the a- and
b-MHC share > 90 % sequence identity, they differ ~ 2-fold in enzymatic and
mechanical properties, raising the possibility that the effect of a disease mu-
tation may depend on the isoform backbone. To address this question we used
a transgenic mouse model in which the endogenous a-MHC was replaced
with transgenically encoded b-MHC. A His-tag was cloned at the N-terminus
of a- and b-MHC, along with the R403Q mutation, to facilitate isolation of
myosin or its head subfragment-1 (S1).We find that the steady-state ATPase
activity and in vitro motility of mouse a-MHC is enhanced by the R403Q mu-
tation, as reported previously, but the R403Q mutation in a b-MHC back-
ground shows a slight reduction in activity. A more in-depth analysis of the
R403Q phenotype is being undertaken by stopped-flow kinetics to measure
the nucleotide turnover in these mutant S1 isoforms. In order to determine
the extent of species-dependent differences, we are comparing the functional
properties of b-cardiac myosin in the mouse with those in the rabbit, a model
system which more closely resembles humans in protein composition and dis-
ease phenotypes.
1154-Symp
Reduced Responsiveness to b-Adrenergic Agonists in Murine cMyBP-C
Cardiomyopathy
Richard L. Moss, Carl Tong.
Univ Wisconsin Sch Med, Madison, WI, USA.
Myosin binding protein C (MyBP-C) is a thick filament accessory protein that
has both structural and regulatory roles in striated muscle contraction. We are
studying the roles of the cardiac isoform of MyBP-C in mouse models in
which the cMyBP-C gene has been disrupted, resulting in ablation of the pro-
tein, and in mice expressing mutant protein in which residues that are phos-
phorylated in vivo by PKA have been replaced with ala or asp. Ablation of
cMyBP-C results in a cardiac phenotype similar to many inherited cardiomy-
opathies in humans, i.e., septal hypertrophy, increased arrhythmic activity,
and systolic and diastolic dysfunction. Studies of isolated myocytes from
wild-type and null mice suggest that cMyBP-C regulates the kinetics ofcross-bridge interaction with actin, a mechanism that is lost in the null mouse.
Studies of myocytes from mouse lines expressing phosphorylation mutants of
cMyBP-C indicate that PKA stimulation of contraction kinetics in myocar-
dium is in large part due to phosphorylation of cMyBP-C, which appears to
relieve a structural constraint on myosin and increases the likelihood of my-
osin binding to actin. Living myocardium expressing non-phosphorylatable
cMyBP-C was found to exhibit depressed twitch force-frequency relationships
and reductions in both frequency-dependent and b-agonist- induced accelera-
tion of relaxation. These results can be explained by a model in which
cMyBP-C phosphorylation accelerates cross-bridge interaction kinetics in
wild-type myocardium, a regulatory mechanism that is lost in myocardium ex-
pressing the non-phosphorylatable mutant cMyBP-C. Supported by NIH R01
HL082900 and P01 HL094291.
1155-Symp
The Giant Elastic Protein Titin Role in Muscle Function and Disease
Henk Granzier.
University of Arizona, Tucson, AZ, USA.
No Abstract.
1156-Symp
Rescue of Familial Cardiomyopathies by Modifications at the Sarcomere
Level and Ca2þ Fluxes
Beata M. Wolska.
University of Illinois, Chicago, Chicago, IL, USA.
Familial cardiomyopathies are commonly linked to missense mutations, dele-
tions or truncations in sarcomeric, cytoskeletal, or intermediate filament
proteins and give rise to hypertrophic cardiomyopathy (HCM), dilated cardio-
myopathy (DCM) or restrictive cardiomyopathy. Although in the last two de-
cades much information about the pathophysiology of genetically linked
HCM and DCM has been provided by studies using transgenic animal models,
there is still no therapy to prevent the development of the disease and increase
survival in patients with HCM or DCM. Our emphasis here is on development
of new therapies for treatment of HCM and DCM linked to mutations in thin
filament proteins that are associated with increased and decreased myofila-
ment sensitivity to Ca2þ respectively. We hypothesize that direct modifica-
tions of myofilament Ca2þ sensitivity and/or alteration in Ca2þ fluxes can
serve as new therapeutic targets. Therefore if 1) HCM is associated with in-
creased myofilament sensitivity to Ca2þ, interventions that desensitize the
myofilament to Ca2þ may serve as potential new therapeutic targets and 2)
DCM is associated with decreased myofilament sensitivity to Ca2þ, interven-
tions that sensitize the myofilament to Ca2þ may serve as potential new ther-
apeutic targets. There are several possible targets within myofilament proteins
for altering myofilament Ca2þ sensitivity, in particular troponin I. Alterations
in Ca2þ regulation by modification of sarcoplasmic reticulum Ca-ATPase
(Serca2) or phospholamban levels are additional potential targets for HCM
and DCM.Minisymposium 2: Nanomedicine: Biophysical
Approaches to Clinical Problems at the
Nanoscale
1157-MiniSymp
4.0 A˚ Cryo-EM Structure of the Mammalian Chaperonin: TRiC/CCT
Yao Cong1, Matthew Baker1, Joanita Jakana1, David Woolford1,
Stefanie Reissmann2, Steven J. Ludtke1, Judith Frydman2, Wah Chiu1.
1Baylor College of Medicine, Houston, TX, USA, 2Stanford University,
Stanford, CA, USA.
TRiC is a eukaryotic chaperonin essential for de novo folding of ~10% newly
synthesized cytosolic proteins, many of which cannot be folded by other cel-
lular chaperones. Unlike prokaryotic and archael chaperonins, each of its two
rings consists of eight unique, but similar subunits. Using single particle cryo-
EM, we determined the mammalian TRiC structure without any symmetry im-
position at 4.7 A˚ resolution, which is the highest resolution asymmetric cryo-
EM reconstruction to date. An analysis of this map allowed us to elucidate the
relative orientation of the two rings and the two-fold symmetry axis location
between them. A subsequent two-fold symmetrized map yielded a 4.0 A˚ struc-
ture, in which a large fraction of side chains and structural elements including
loops and insertions appear as visible densities. These features permitted
unambiguous identification of all eight individual subunits, despite their sim-
ilarity. A Ca backbone model of the entire TRiC complex was subsequently
refined from initial homology models against the cryo-EM density based on
our subunit identification. A refined all-atom model for a single subunit
Monday, February 22, 2010 223ashowed ~95% of the dihedral angles in the allowable regions of the Rama-
chandran plot. Our model reveals that the cavity walls of TRiC exhibit an
overall positively charged surface property, the opposite of GroEL. The inte-
rior surface chemical properties likely play an important role for TRiC’s
unique substrate specificity.
1158-MiniSymp
Counting Hydrolyzed ATP On Single Tric Nanomachines in Solution
Yan Jiang, Nick Douglas, Nick Conley, Judith Frydman, W.E. Moerner.
Stanford University, Stanford, CA, USA.
Single biomolecules can be localized in aqueous solution using an Anti-
Brownian Electrokinetic (ABEL) trap, which uses fluorescence imaging com-
bined with actively applied electrokinetic forces in a microfluidic geometry.
With this device, we have explored the ATP-induced cooperative transitions
in the important multi-subunit eukaryotic chaperonin TRiC, a model for other
multisubunit enzymes. ATP is labeled with Cy3 and incubated with Atto647
labeled TRiC in the presence of AlFx. The ATPs bind to up to 16 subunits in
TRiC and are locked in their binding sites by AlFx after hydrolysis. A rotat-
ing 532nm confocal excitation beam is used for both trapping and measuring,
and each TRiC complex is trapped until complete photobleaching of the Cy3
occurs. The number of photobleaching steps in the fluorescent intensity trace
yields the number of hydrolyzed ATPs. In a separate measurement the total
number of TRiCs and the number of TRiCs with one or more ATPs are de-
termined. From these measurements, we obtain the distribution of the number
of ATPs on each TRiC at different incubation ATP concentrations. As the
ATP concentration increases from 25uM, the position of the major peak re-
mains at 7-8 ATP/chaperonin while the height of the peak increases. For ATP
concentrations above 200uM, all the TRiCs are found to have 7-8 ATP bound
with a smaller probability of 6 or 9 ATP bound, and no other peak appears up
to an ATP concentration of 1.5mM, suggesting each ring hydrolyzes at most
4 ATP. Only when the ATP concentration is lower than 25uM does the peak
position move to smaller numbers. While the averages of our distributions
can be fit with MWC model, the distributions themselves depart from the
model. This new method may be applied to study the cooperativity behavior
of other multi-subunit enzymes.
1159-MiniSymp
Reconstituting EphA2-Ephrin Signaling with Supported Membranes
Jay T. Groves, Rebecca Petit.
UC Berkeley, Berkeley, CA, USA.
The Eph family of receptor tyrosine kinases mediates cell patterning and tissue
organization via their ability to govern intercellular interactions. Eph activation
occurs when cell surface Eph receptors encounter their ligands, the ephrins,
presented on the membrane of an adjacent cell. The resultant intracellular sig-
naling strongly influences whether the eventual outcome of the cell-cell contact
event will be adhesion or repulsion. Here, we examine the complex interplay
between spatial, mechanical and biochemical regulation mechanisms in EphA2
signaling.
We recapitulate the native intercellular signaling geometry using a hybrid junc-
tion between live human breast cancer cells expressing EphA2 and a supported
membrane functionalized with ephrin-A1. After cells contact the membrane for
1 hour, we observe spatial reorganization of EphA2-ephrin-A1 complexes on
multiple lengthscales as well as pronounced changes in cell shape and signaling
activity.
To further probe the reorganization phenomenon, we have investigated a panel
of membrane-associated effector proteins with functions associated with
motility and cytoskeletal remodeling to determine how they are affected by
EphA2 reorganization. These observations provide new insight regarding
the cellular transduction of spatio-mechanical feedback into biochemical
signaling.
1160-MiniSymp
Engineering Vesicle Membranes for Cellular Reconstitutions
David L. Richmond, Eva M. Schmid, Sascha Martens,
Jeanne C. Stachowiak, Nicole Liska, Daniel A. Fletcher.
UC Berkeley, Berkeley, CA, USA.
Cells routinely sample their local environment, process this information through
internal signaling, and respond accordingly. However, the sheer complexity that
underlies cellular behavior makes cells notoriously difficult to understand and
control. To address these issues, traditional cell biological approaches are often
complemented with in vitro reconstitutions aimed at building ‘cell-like’ systems
from individual components. Such reconstitutions can provide functional in-
sights into biological processes and have great potential for improving drug
delivery. However, these studies are still limited by the technical challenge of
assembling giant lipid vesicles with embedded transmembrane (TM) proteins
and complex cytosolic components.Here we present a method for incorporating TM proteins into giant unilamellar
vesicles (GUVs) with simultaneous control over the encapsulated components.
This method is an extension of a previously developed microfluidic jetting tech-
nique for creating GUVs from planar bilayers, analogous to blowing bubbles
from a soap film. The technique can now be used to incorporate TM proteins
with controlled orientation and create an asymmetric lipid bilayer composition
in order to assemble increasingly sophisticated ‘cell-like’ systems.
With this approach, we demonstrate encapsulation of small unilamellar vesicles
(SUVs) carrying the vesicular fusion machinery (vSNAREs) into GUVs carry-
ing the target fusion machinery (tSNAREs), closely mimicking the organiza-
tion of synaptic vesicles in cells. Using fluorescence microscopy we track the
location of SUVs in the lumen of GUVs and study the role of vesicle docking
in the process of SNARE-mediated membrane fusion.
1161-MiniSymp
A Light-Gated, Potassium-Selective Glutamate Receptor for the Optical
Inhibition of Neuronal Firing
Harald Janovjak1, Dirk Trauner2, Ehud Y. Isacoff1.
1UC Berkeley, Berkeley, CA, USA, 2University of Munich, Munich,
Germany.
Genetically-targeted, light-activated ion channels and pumps have recently
made it possible to manipulate activity in specific neurons and thereby probe
their role in neuronal circuits, information processing and behavior. Here, we
describe the development of a Kþ-selective ionotropic glutamate receptor that
inhibits nerve activity in response to light. The receptor is a chimera of the pore
region of a Kþ-selective bacterial glutamate receptor and the ligand binding
domain of the light-gated mammalian kainate receptor LiGluR (iGluR6/
GluK2). This new hyperpolarizing light-gated channel is turned ON and OFF
by brief light pulses even at moderate light intensities. After optical activation
the silencing of neuronal activity persist in the dark for extended periods, a
feature that will prove advantageous for the dissection of neural circuitry in
behaving animals.
1162-MiniSymp
Computational Nanomedicine: Simulating Protein Misfolding Disease
Vijay Pande.
Stanford Univ, Stanford, CA, USA.
Protein misfolding diseases such as Alzheimer’s Disease (AD) and Hunting-
ton’s Disease (HD) are challenging to study experimentally. Thus, computa-
tional methods, if they are able to be sufficiently accurate and reach sufficiently
long timescales, can naturall contribute in this challenging area. I will discuss
our recent results using novel methods within the Folding@home distributed
computing project on progress towards a molecular understanding of protein
aggregation involved in AD and HD. Specifically, I will detail our extensions
to simulation Markov State Model methodology as well as specific predictions
that arose from these simulations and experimental validation of these predic-
tions. These results lead to a novel hypothesis for the structural basis of Abeta
aggregation as well as the ability to explain existing experimental data.Platform X: Membrane Protein Functions
1163-Plat
Using Giant Uni-Lamellar Vesicles to Study Ion Channel Activity and
Interactions
Sophie Aimon, Gilman ES Toombes, Patricia Bassereau.
Institut Curie, Paris, France.
Unraveling the complicated dynamics of ion channel activity and interactions
requires experimental systems in which ion channel activity and distribution
can be measured while controlling ion channel concentration and membrane
composition, tension and voltage. Many of the constraints imposed by existing
techniques, such as planar Black Lipid Membranes (BLM), could potentially be
circumvented by using Giant Uni-Lamellar Vesicles (GUVs). To explore this
possibility, a method was developed to produce GUVs containing KvAP, a bac-
terial voltage-gated potassium channel [1]. Protein was first purified, fluores-
cently labeled and reconstituted into Small Unilamellar Vesicles (SUVs) which
were then used to grow GUVs via an electro-formation procedure [2]. Incorpo-
ration of the fluorescently-labeled channels was confirmed via confocal micros-
copy while channel activity was studied with the patch-clamp technique. In
parallel, attempts were made to adapt the "whole-cell" patch-clamp geometry
for GUVs. While the absence of a cytoskeleton made the "whole-GUV" config-
uration quite difficult, this geometry is possible and its further development is
important since it permits simultaneous control of the voltage inside the GUV
and measurement of the entire membrane current. These results confirm the po-
tential of GUVs for ion channel studies, and experiments measuring the effect
